Including imaging and cerebrospinal fluid biomarkers, a combination of diagnostic tests can improve prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease. This is according to a new study published online in the journal iRadiology/i. "Because new treatments are likely to be most effective at the earliest stages of Alzheimer's disease, there is great urgency to develop sensitive markers that facilitate detection and ...Monday, 17 December 2012
Combination of Diagnostic Tests Improves Alzheimer's Disease
Including imaging and cerebrospinal fluid biomarkers, a combination of diagnostic tests can improve prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease. This is according to a new study published online in the journal iRadiology/i. "Because new treatments are likely to be most effective at the earliest stages of Alzheimer's disease, there is great urgency to develop sensitive markers that facilitate detection and ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment